B LYMPHOBLASTIC LYMPHOMA
Clinical trials for B LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for B LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a targeted antibody boost leukemia survival in High-Risk kids?
Disease control Recruiting nowThis large phase 3 study is testing whether adding a targeted drug called inotuzumab ozogamicin to standard chemotherapy and immunotherapy can improve outcomes for children and young adults with high-risk B-cell acute lymphoblastic leukemia (B-ALL). The drug works like a guided m…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 26, 2026 04:45 UTC
-
Promising new combo therapy aims to improve leukemia treatment
Disease control Recruiting nowThis study is for adults newly diagnosed with B-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. It tests a treatment plan that combines standard chemotherapy (Hyper-CVAD) with two targeted drugs: blinatumomab and inotuzumab ozogamicin. The goal is to see if thi…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Can we safely give fewer blood transfusions to leukemia patients?
Knowledge-focused Recruiting nowThis study looks at whether giving red blood cell transfusions only when hemoglobin drops below 7 gm/dL (instead of 9 gm/dL) is safe and maintains quality of life in adults with acute leukemia or related cancers who have had chemotherapy or a stem cell transplant. About 50 partic…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 26, 2026 04:44 UTC